CHIMERIC ANTIGEN RECEPTORS AND THEIR USES Read more about CHIMERIC ANTIGEN RECEPTORS AND THEIR USES China201880032676.5Filed on 2018-05-15
BICISTRONIC CHIMERIC ANTIGEN RECEPTORS AND THEIR USES Read more about BICISTRONIC CHIMERIC ANTIGEN RECEPTORS AND THEIR USES Canada3062433Filed on 2018-05-15
CHIMERIC ANTIGEN RECEPTORS AND THEIR USES Read more about CHIMERIC ANTIGEN RECEPTORS AND THEIR USES Australia2018269194Filed on 2019-10-28
T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 Read more about T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 European Patent19212016.0Filed on 2019-11-28
Compositions And Methods For Modulation Of LMNA Expression Read more about Compositions And Methods For Modulation Of LMNA Expression Patent Cooperation TreatyPCT/US2019/052223Filed on 2019-09-20
EPOXYAZULENE DERIVATIVES USEFUL FOR TREATING CANCER Read more about EPOXYAZULENE DERIVATIVES USEFUL FOR TREATING CANCER Sweden16718144.5Filed on 2016-04-13
EPOXYAZULENE DERIVATIVES USEFUL FOR TREATING CANCER Read more about EPOXYAZULENE DERIVATIVES USEFUL FOR TREATING CANCER Norway16718144.5Filed on 2016-04-13
EPOXYAZULENE DERIVATIVES USEFUL FOR TREATING CANCER Read more about EPOXYAZULENE DERIVATIVES USEFUL FOR TREATING CANCER Italy16718144.5Filed on 2016-04-13
EPOXYAZULENE DERIVATIVES USEFUL FOR TREATING CANCER Read more about EPOXYAZULENE DERIVATIVES USEFUL FOR TREATING CANCER United Kingdom16718144.5Filed on 2016-04-13
EPOXYAZULENE DERIVATIVES USEFUL FOR TREATING CANCER Read more about EPOXYAZULENE DERIVATIVES USEFUL FOR TREATING CANCER France16718144.5Filed on 2016-04-13